Director of START Madrid-FJD
START Madrid-FJD, Fundación Jiménez Díaz
Madrid, Madrid, Spain
Dr. Moreno earned his Medical Degree in Universidad Complutense de Madrid in 2004 and completed his training as a medical resident in Medical Oncology between 2005 and 2009 in Hospital La Paz, Madrid, where he conducted his Ph.D. in Molecular Biology in Cancer. Here he received the Excellent Resident (REX) Grant 2009, (Fundación para la investigación biomédica del Hospital Universitario La Paz) and he was also a member of the Executive Committee of the +MIR section at the Spanish Society of Medical Oncology (SEOM) (2012-2014). Moreover, he conducted a Master Degree in Medical Oncology in Centro Nacional de Investigaciones Oncológicas in 2010.
As a researcher his main interest are early clinical trials, drug development cancer immunotherapy, adoptive t cell therapy, targeted therapy and predictive biomarkers in early clinical trials. Dr. Moreno has published more than 80 scientific articles and has participated in more than 150 clinical trials, in fact, he is involved in multiple early phase clinical trials related to different tumors.
He is also member of the Spanish Society of Medical Oncology since 2007, the American Society of Clinical Oncology (ASCO) since 2011, the European Society of Medical Oncolgy (ESMO) since 2011, the American Association for Cancer Research (AACR) since 2012 and the Spanish Group for Research in Neurooncology (GEINO) since 2012.
Disclosure information not submitted.
